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IMPORTANCE As the US population ages, the number of operations performed on elderly
patients will likely increase. Frailty predicts postoperative mortality andmorbidity more than
age alone, thus presenting opportunities to identify the highest-risk surgical patients and
improve their outcomes.
OBJECTIVE To examine the effect of the Frailty Screening Initiative (FSI) onmortality and
complications by comparing the surgical outcomes of a cohort of surgical patients treated
before and after implementation of the FSI.
DESIGN, SETTING, AND PARTICIPANTS This single-site, facility-wide, prospective cohort quality
improvement project studied all 9153 patients from a level 1b Veterans Affairs medical center
who presented for major, elective, noncardiac surgery fromOctober 1, 2007, to July 1, 2014.
INTERVENTIONS Assessment of preoperative frailty in all patients scheduled for elective
surgery began in July 2011. Frailty was assessed with the Risk Analysis Index (RAI), and the
records of all frail patients (RAI score,21) were flagged for administrative review by the
chief of surgery (or designee) before the scheduled operation. On the basis of this review,
clinicians from surgery, anesthesia, critical care, and palliative care were notified of the
patient’s frailty and associated surgical risks; if indicated, perioperative plans were modified
based on team input.
MAIN OUTCOMES ANDMEASURES Postoperativemortality at 30, 180, and 365 days.
RESULTS FromOctober 1, 2007, to July 1, 2014, a total of 9153 patients underwent surgery
(mean [SD] age, 60.3 [13.5] years; female, 653 [7.1%]; and white, 7096 [79.8%]). Overall
30-daymortality decreased from 1.6% (84 of 5275 patients) to 0.7% (26 of 3878 patients,
P < .001) after FSI implementation. Improvement was greatest among frail patients (12.2%
[24 of 197 patients] to 3.8% [16 of 424 patients], P < .001), althoughmortality rates also
decreased among the robust patients (1.2% [60 of 5078 patients] to 0.3% [10 of 3454
patients], P < .001). Themagnitude of improvement among frail patients increased at 180
(23.9% [47 of 197 patients] to 7.7% [30 of 389 patients], P < .001) and 365 days (34.5% [68
of 197 patients] to 11.7% [36 of 309 patients], P < .001). Multivariable models revealed
improved survival after FSI implementation, controlling for age, frailty, and predicted
mortality (adjusted odds ratio for 180-day survival, 2.87; 95% CI, 1.98-4.16).
CONCLUSIONS AND RELEVANCE Implementation of the FSI was associated with reduced
mortality, suggesting the feasibility of widespread screening of patients preoperatively to
identify frailty and the efficacy of system-level initiatives aimed at improving their surgical
outcomes. Additional investigation is required to establish a causal connection.
JAMA Surg. 2017;152(3):233-240. doi:10.1001/jamasurg.2016.4219
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M any patients older than 65 years undergo surgery.1For some, surgerywill confer substantialbenefits (eg,extended life, improved quality of life). For others,
surgerywill confer burdens for patients, families, and society
at large (eg, pain, distress, increased inpatient admissions, in-
stitutionalization, financialhardship,and increasedhealthcare
costs).2,3 Thus, there is an imperative to identify patients at
greatest risk for harm, ensure their decision-making process
regardingsurgery ispatientcentered,andprovidetailoredclini-
cal care to improve surgical outcomes in high-risk patients.
Recent data indicate that frailty is a more powerful pre-
dictorof increasedperioperativemortality,morbidity, andcost
thanpredictions basedonageor comorbidity alone.2-7 For ex-
ample,when comparedwith robust patients, frail surgical pa-
tients are less likely to be discharged to home,6more likely to
be readmitted to thehospitalwithin30days,3,7 andmore likely
to have substantially increased rates of perioperativemortal-
ity and complications.2,4,5,7,8 As such, measuring frailty sub-
stantially improves the receiveroperatingcharacteristicofpre-
dicting mortality andmorbidity when compared with classic
tools, suchasAmericanSocietyofAnesthesiologists (ASA)clas-
sification and the Lee criteria, which systematically underes-
timate mortality and morbidity in high-risk populations and
are not suitable for rapid, system-level screening.5,7,9-11 How-
ever, to our knowledge, no published studies have examined
facility-wide preoperative screening for frailty aimed at im-
proving the care and outcomes of these vulnerable surgical
patients.
The Surgical Service Line at the Veterans Affairs (VA) Ne-
braska–Western IowaHealthCare System(NWIHCS) inOmaha
conducts 3600 operations annually, of which 41.8% are per-
formed in those 65 years or older. Before 2011, preoperative
risk assessment at theNWIHCS focusedon traditional cardio-
pulmonary testingandevaluationbyanesthesia.However, be-
cause of increasing postoperative mortality in 5 of 7 quarters
before July 2011, the NWIHCS chief of surgery (J.M.J.) de-
signed and implemented a quality improvement (QI) project
called the Frailty Screening Initiative (FSI) aimed at improv-
ingpostoperative survival. TheFSI screened for frailty among
all patients considering elective surgery, and for those iden-
tified as frail, the FSI reviewed the surgical decision making
with surgeons, anesthesiologists, and palliative care physi-
cians. Informedby theStandards forQuality ImprovementRe-
portingExcellence 2 guidelines for reportingQI projects,12we
examined the effect of the FSI on mortality and complica-
tions by comparing the surgical outcomes of a cohort of
surgical patients treated before and after implementation of
the FSI.
Methods
Context
TheFSIwasconductedat theNWIHCStoaddressaclinicalneed
of increased rates of case- and complexity-adjusted postop-
erative mortality. The NWIHCS is a large level 1b hospital at
which 3600 operations are performed per year across 12 sur-
gical service divisions (general surgery, vascular surgery, tho-
racic surgery, plastic surgery, urology, otolaryngology, oph-
thalmology, neurosurgery, orthopedics, oral maxillofacial,
gynecology, and podiatry). Once a patient and surgeon agree
to pursue surgery, the procedure is posted to the operating
roomschedule, and thepatient is referred to thesurgical evalu-
ation unit (SEU) for perioperative risk assessment and man-
agement. The workup typically focuses on cardiopulmonary
testingandoptimization, but after implementing theFSI, it ex-
panded to include frailty assessment.
TheNWIHCS InstitutionalReviewBoarddetermined these
procedures to be an operations activity not constituting re-
search, and thus, per Veterans Health Administration policy
(Handbook 1058.0513), the information presented in this ar-
ticle does not require informed consent or institutional re-
view board approval.
Intervention
The FSI consisted of 2 parts: (1) screening for frailty with the
goal of rapid assessmentwithoutneed forpatientmedical rec-
ord access and (2) review of surgical decisionmaking. Begin-
ning in July 2011, all patients presenting for elective surgical
procedures at theNWIHCSwere screened for frailty using the
Risk Analysis Index (RAI) as part of the standard intake ex-
amination at the outpatient surgical clinics. The RAI is a 14-
item questionnaire that takes less than 2 minutes to com-
plete in a nonfrail patient, generates scores ranging from0 to
81, andpowerfullypredictspostoperativemortality.14-17 Toen-
sure adherence, theRAI scorewas required to schedule anop-
eration.
Patients identified as frail (RAI score, ≥21)were flaggedby
the surgical quality nurse (G.P.) for administrative review by
the chief of surgery (J.M.J.) or his designee. Reviewers in-
cluded surgeons with a range of experience from senior staff
to house officers. Reviewers examined the electronic medi-
cal record of each patient identified as frail to clarify decision
making regarding surgery andoptimizeperioperative care. In-
terventions included informal discussions with the sur-
geons, anesthesiologists, and critical carephysicians aimedat
alerting them to the patient’s frailty, the attendant risks, and
patient prognosis for 6-month mortality. When appropriate,
formal preoperative palliative care consultation focused on
Key Points
Question Can surgical outcomes of frail patients be improved by
facility-wide frailty screening and subsequent administrative
review of perioperative surgical decisionmaking?
Findings After implementing a quality improvement project
called the Frailty Screening Initiative in a prospective cohort of
9153 patients who underwent surgery, postoperative mortality
decreased significantly at 30, 180, and 365 days. Multivariate
models revealed a 3-fold survival benefit after controlling for age,
frailty, and predictedmortality.
Meaning Frailty screening of preoperative patients is feasible and
may be an effective tool for improving surgical outcomes for an
aging and increasingly frail US population.
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clarifying goals and expectations for the surgery and postop-
erative recovery, includingdiscussions regardingventilatorde-
pendence, dialysis, and do-not-resuscitate or do-not-
intubate status.
The goals of the FSI were clearly focused on assisting and
enhancing the decision making shared by surgeon and pa-
tient, and the frailty score was never used to refuse an opera-
tion that the surgeon and patient wanted to pursue. How-
ever, it is likely that the frailty diagnosis occasionally changed
thedecision tooperate, the choiceof specificprocedure, or the
anesthetic plan, although because of the operational focus of
thisQIproject,wewerenot able to capturequalitativeorquan-
titative details about those changes. Nonetheless, the opera-
tive volumeat theNWIHCSdidnot change substantively, sug-
gestingthatmostoperationsproceededasplanned. Inaddition,
and as described previously in a subgroup analysis of this
cohort,15 the FSI significantly changed the pattern of pallia-
tive care consultation such that, after implementing the FSI,
palliative care consultation was most often ordered before
rather than after the operation and by a surgeon rather than
an intensivist or hospitalist.
Statistical Analysis
To examine the effect of the FSI, we analyzed prospectively
collected data from a cohort of patients treated at the NWI-
HCS from October 1, 2007, to July 1, 2014. These data were
drawn fromaQI databasemaintained by theNWIHCS that in-
cludes multiple quality variables, including all variables ab-
stracted throughtheVeteransAffairsSurgicalQuality Improve-
ment Program (VASQIP). The database constitutes a
representative sampleof all thenoncardiac,major elective sur-
gicalproceduresconductedat theNWIHCS.18Wefurther linked
these data to the US Department of Veterans Affairs vital sta-
tistics file to capture dates of death for all patients who had
died.
To measure frailty in this cohort retrospectively, we
mapped VASQIP variables to each of the 14 items of the RAI
and calculated anRAI score as described elsewhere.14Wealso
calculated the modified Frailty Index as previously
described4,19 and used by others.20 We calculated the length
of survival from the date of surgery to the date of death, pre-
suming that patients without a date of death remained alive.
Mortality ratesbeforeandafterFSI implementationwere com-
pared using the Pearson χ2 tests. Two-sided P < .05 was con-
sideredsignificant.Multivariable logistic regressionmodelsex-
amined the effect of the FSI on mortality, controlling for age
and frailty. For illustrative purposes, we plotted Kaplan-
Meier survival curves stratified by RAI score for the cohorts
before and after FSI implementation, comparing the curves
withpairwiseMantel-Cox log rank tests.All analyseswerecon-
ducted using SPSS statistical software, version 23 (IBM Inc).
Results
Development and testing of the FSI began in July 2010. Ret-
rospective analysis of a cohort of patientswithhip fracture re-
vealed theRAI’spromisingability topredictpostoperativemor-
bidity andmortality. Pilot tests in small convenience samples
of outpatients confirmed the RAI’s ease of clinical adminis-
tration. On the basis of these data, we began screening pa-
tientswith the RAI in the SEU inOctober 2010. This approach
confirmed our ability to identify a limited group of frail pa-
tients athigh risk, butwe learned that screening in theSEUwas
not ideal because not all patients were evaluated by the SEU
anddiagnosis of frailtywasdelayeduntil after thedecision for
or against surgical treatment. We therefore moved the frailty
screen upstream, deploying the RAI to select surgical clinics
in January 2011, with increasing adoption during 2 quarters.
Weekly assessment and feedback to clinics revealed increas-
ing adherence innearly90%ofelective surgical patients being
assessed. Given the positive feedback from the effected sur-
gical services,wemade theRAI scoremandatory in July 2011:
the case schedulerwas instructed to record theRAI score into
the electronic medical record, thus achieving near 100% ad-
herence for elective surgical procedures.
Administrative reviewof frail patients initially focusedon
clarifying the operative plan through discussion between the
reviewer and the surgeonof record.During the first 6months,
the review rapidly expanded to include formal and informal
consultation with anesthesiologists and critical care physi-
cians todevelopplans for intraoperativeandpostoperativecare
informed by geriatric care principles and strategies for early
recognition and treatment of expected complications (eg, res-
cue therapy). In addition, the reviewer recommended preop-
erative palliative care consultation to the surgeon of record
when themedical record did not document a clear discussion
of the patient’s goals of care or the high risk of surgery in the
setting of frailty.
The analysis includes data from a prospective cohort of
9153patientswhounderwent surgeryat theNWIHCS fromOc-
tober 1, 2007, to July 1, 2014 (mean [SD] age, 60.3 [13.5] years;
653 females [7.1%] and 7096 white [79.8%]). These patients
includedall those in the localVASQIP-relatedQIdatabasewho
were alsomatched to the vital statistics file for long-term sur-
vival and mortality. Demographic characteristics of the pa-
tients treated before and after FSI implementation (July 2011)
were similar with regard to age, sex, race, ASA classification,
and comorbidity (Table 1). Most patients were not frail, with
only 6.8% scoring 21 or higher on the RAI and only 11.1% scor-
inghigher than0.27on themodifiedFrailty Index. Patient age
and frailty were similar before and after FSI implementation
(mean [SD] ageof 60.3 [13.4] years before and60.3 [13.7] years
after,mean [SD]RAI scoreof8.36 [4.86]beforeand10.33 [7.38]
after, andmean[SD]modifiedFrailty Indexscoreof0.20 [0.10]
before and 0.20 [0.10] after). As expected, mortality rates in-
creasedwith frailty (Table 2). For example, 180-daymortality
increased from 1.6% (113 of 7217 patients) among those with
the lowestRAI scores to 29.6% (16of 54patients) among those
with the highest RAI scores.
As reported in Table 3, overall 30-day mortality de-
creased from1.6% (84of 5275patients) to0.7% (26of 3878pa-
tients) (P < .001) after FSI implementation. Improvementwas
greatest among frail patients (12.2%[24of 197patients] to3.8%
[16of424patients],P < .001), althoughmortality rates alsode-
creased among robust patients (1.2% [60 of 5078 patients] to
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0.3% [10 of 3454 patients], P < .001). The magnitude of im-
provement among frail patients increased at 180 (23.9% [47
of 197 patients] to 7.7% [30 of 389 patients],P < .001) and 365
days (34.5% [68 of 197 patients] to 11.7% [36 of 309 patients],
P < .001). Kaplan-Meier curves (Figure) reveal that increas-
ing frailty is associatedwith an increased riskofdeathbut that
these risks were significantly reduced after FSI implementa-
tion (P < .001).
Multivariablemodels controlling for age andRAI score re-
vealed that postoperative survival improved at each time ho-
rizon (Table 4). To examinewhat portion of the effect was at-
tributable to the intervention, we added to our model an
interaction between FSI implementation and frailty (eg, RAI
score>21).At 30days, the interactionwasnot a significantpre-
dictor ofmortality (P = .66), but the interactionpredicted sur-
vival at 180 and 365 days (Table 4). Finally, for all but 418 pa-
tients, our data included theprobability of deathpredictedby
the VASQIP algorithms based on patient- and procedure-
related risk factors. Adding this to our model diminished the
magnitudeof themaineffect slightly, but theoverarching find-
ingsof theanalysis remained robust after this control (Table4),
confirming the independent role of the screening initiative in
decreasing mortality.
Discussion
This study reveals the feasibilityof facility-wide frailty screen-
ing in elective surgical populations. It also suggests the po-
tential to improve postoperative survival among the frail
through systematic administrative screening, review, andop-
timization of perioperative plans. The absolute reduction in
180-day mortality among frail patients was more than 19%,
Table 2. Prevalence of Frailty and Associated 30-DayMortality asMeasured by RAI andmFIa
Variable No. (%) in Cohort
Mortality, %
30 d
(n = 9153 for RAI and
6639 for mFI)
180 d
(n = 8667 for RAI and
6638 for mFI)
365 d
(n = 8056 for RAI and
6638 for mFI)
RAI score stratum
0-10 7576 (82.8) 0.4 1.6 2.6
11-15 550 (6.0) 2.9 9.1 13.2
16-20 406 (4.4) 5.7 14.4 18.9
21-25 368 (4.0) 4.1 8.7 14.0
26-30 63 (0.7) 9.5 20.3 32.0
31-35 132 (1.4) 7.6 14.8 27.0
36-62 58 (0.6) 15.5 29.6 32.7
Overall 9153 (100) 1.2 3.3 4.9
mFI score
0.09 1932 (29.1) 0.3 1.3 1.5
0.18 2613 (39.4) 0.7 2.5 3.8
0.27 1360 (20.5) 2.4 5.7 8.0
0.36 510 (7.7) 3.9 9.2 12.0
0.45 165 (2.5) 9.1 16.4 23.6
0.55 45 (0.7) 2.2 6.7 13.3
>0.63 14 (0.2) 14.3 21.4 21.4
Overall 6639 (100) 1.4 3.7 5.3
Abbreviations: mFI, modified Frailty
Index; RAI, Risk Analysis Index.
a The RAI scores were calculated for
all 9153 patients and sorted into
categories. Because of missing data,
the mFI scores were calculated for
only 6639 of these patients and
sorted into categories. For each
category, the table reports the
number of patients and the
within-category mortality rate at 30,
180, and 365 days.
Table 1. Demographic Characteristics of 9153 Surgical Patients From
2007 to 2014a
Characteristic
No. (%) of Patients
Before FSI
(n = 5275)
After FSI
(n = 3878)
Sex
Male 4876 (92.4) 3624 (93.5)
Female 399 (7.6) 254 (6.5)
Race (n = 8896)
American Indian or Alaska
Native
45 (0.9) 45 (1.2)
Asian 1 (0.0) 0 (0.0)
Black or African American 77 (1.5) 39 (1.0)
Declined to answer 305 (5.9) 180 (4.8)
Native Hawaiian or Pacific
Islander
4 (0.1) 6 (0.2)
White 4042 (78.8) 3054 (81.1)
Unknown by patient 654 (12.8) 444 (11.8)
ASA class (n = 9118)
1 120 (2.3) 73 (1.9)
2 1015 (19.3) 731 (18.9)
3 3781 (72.0) 2755 (71.3)
4 334 (6.4) 299 (7.7)
5 5 (0.1) 5 (0.1)
CHF 27 (0.5) 7 (0.2)
COPD 987 (18.7) 328 (8.5)
Renal insufficiency 24 (0.5) 22 (0.6)
Abbreviations: ASA, American Society of Anesthesiologists; CHF, congestive
heart failure; COPD, chronic obstructive pulmonary disease; FSI, Frailty
Screening Initiative.
a Sample sizes change depending on race, ASA classification, andmissing
modified Frailty Index variables.
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with improvement remaining robust evenafter controlling for
age, frailty, and predicted mortality.
Although the initiative was aimed primarily at frail pa-
tients, improvements were noted among both frail and ro-
bust patients. This finding is likely because of a Hawthorne
effect.21,22However, improvementwasgreatestamongfrailpa-
tients at 180 and 365 days (odds ratios, 2.19 and 1.88, respec-
tively) but not at 30 days. This finding is significant because
theRAIwasdesigned topredictmedium-termmortality at 180
days. By identifying frail patients (eg, RAI score ≥21) and tar-
geting interventionsbasedongeriatricdomains, it appears that
the FSI effectivelymitigated the longer-term risks associated
Table 3. Change inMortality Before and After Implementing the FSIa
30-d Mortality 180-d Mortality 365-d Mortality
Before FSI After FSI Total Before FSI After FSI Total Before FSI After FSI Total
Overall
No. dead 84 26 110 223 66 289 320 78 398
No. at risk 5275 3878 9153 5275 3392 8667 5275 2781 8056
Mortality rate, % 1.6 0.7 1.2 4.2 1.9 3.3 6.1 2.8 4.9
Nonfrail
No. dead 60 10 70 176 36 212 252 42 294
No. at risk 5078 3454 8532 5078 3003 8081 5078 2472 7550
Mortality rate, % 1.2 0.3 0.8 3.5 1.2 2.6 5.0 1.7 3.9
Frail
No. dead 24 16 40 47 30 77 68 36 104
No. at risk 197 424 621 197 389 586 197 309 506
Mortality rate, % 12.2 3.8 6.4 23.9 7.7 13.1 34.5 11.7 20.6
Abbreviation: FSI, Frailty Screening Initiative.
a Differences betweenmortality before and after implementing the FSI were
tested using the Pearson χ2 test. Differences were significant at every time
horizon and in every group (frail, nonfrail, and overall) at P < .001. Patients
with a Risk Analysis Index of 21 or higher were considered frail. The number
(percentage) of frail patients was 621 (6.8%) at 30 days, 586 (6.8%) at 180
days, and 506 (6.3%) at 365 days.
Figure. The Effect of Frailty on Survival Before and After Frailty Screening Initiative (FSI) Implementation
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The sample included all 9153 patients (5275 before FSI implementation and
3878 after FSI implementation). Mantel-Cox log rank tests for differences in the
survival distribution are as follows (P < .001 for overall difference before and
after FSI implementation). Before FSI implementation, the lowest 2 strata of
frailty were different from each other and from all the other strata (all P < .001).
There was no difference between the 16 to 20 and 21 to 25 Risk Analysis Index
(RAI) strata (P = .31), although the 16 to 20 RAI stratumwas different from the
highest 3 strata of frailty (all P < .05). The 21 to 25 RAI stratumwas not different
from the 26 to 30 (P = .16) or the 31 to 35 (P = .24) RAI stratum, but it was
different from the 36 to 62 RAI stratum (P = .004). Although the lines of the
highest 3 strata diverge, the differences did not reach statistical significance (all
P > .05); however, this is likely attributable to the low numbers in these RAI
strata. After FSI implementation, the lowest frailty stratumwas different from
all others (P < .001), but there was no difference between the next RAI strata
(eg, 11-15, 16-20, and 21-25; all P > .20), although these 3 were different from the
top 3 strata (all P < .03). There was no difference between the top 3 strata (eg,
26-30, 31-35, and 36-62; all P > .50), but they were all different from each of the
lowest 3 strata (all P < .05). Hashmarks indicate censored data.
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with frailty itself. This finding also suggests that it takesmore
than 30 days to detect the effect of these interventions, fur-
ther delineating the limitations of 30-day outcomes noted by
others.23,24
The ultimate cause of the survival benefit is likely multi-
factorial, including changes in preoperative decisionmaking,
intraoperativemanagement, andpostoperative rescue.A con-
sensus panel outlined several potential targets for improving
the perioperative management of frail patients, including
frailty-specific anesthetic plans, clarified goals of care identi-
fied in the preoperative setting, and improved postoperative
management.25 Postoperative rescue therapy deserves spe-
cific consideration. Research reveals that major complica-
tionsoccur in40%of frail patients aftermajor operations, and
thus frail patients frequently require attempts at rescue from
those complications.20 By identifying frail patients at great-
est risk for complications, the FSI may have raised the vigi-
lanceof clinicians to recognize those complicationsearlier and
treat them more effectively. In addition, we suspect that in-
creasing reliance on preoperative palliative care consultation
andformal,preoperativedocumentationofgoalsmayhave im-
proved the rateof rescuebybetterdelineating thepatient’s ex-
pectations regarding rescue therapies, suchasventilatorman-
agement or dialysis in the immediate postoperative period. In
fact, on more than one occasion, NWIHCS clinicians de-
scribed situationswhen a patient became incapacitated from
a complication in the postoperative period: the surrogate de-
cisionmaker initiatedconversationsaboutwithdrawalof care,
but the palliative care consultant’s note clearly stated the pa-
tient’s intention to pursue aggressive rescue therapies for at
least a time-limited trial.Having theseexpectationswell docu-
mented by somebody other than the surgeonmay help build
consensus among patients’ families and clinicians, thus giv-
ing rescue therapies adequate time to treat some of the sur-
vivable complications that frail patients predictably incur. Fi-
nally, on the basis of improvement in survival not only at 30
days but also at 180 and 365 days, we suspect postdischarge
care and social support were also improved through engage-
ment of the family in the entire operative process, including
long-term recovery.
Although our data cannot quantify how the FSI changed
perioperative decision making, it is likely that some frail pa-
tientsdidnotundergosurgeryandare thusnot included in this
analysis. This potential selection bias could explain some of
the effect. However, the mean frailty of the cohort after FSI
implementationwasactuallyhigher than that in thecohortbe-
foreFSI implementation (meanRAI scores, 10.33vs8.36), sug-
gesting thatmany frail patients continued to seek and secure
surgical treatment—even in light of preoperatively diagnosed
frailty. In a previously published subgroup analysis of 310 of
these patients receivingpalliative care consultations,we con-
trolled for whether patients underwent surgery, and the sur-
vival benefit remained robust (odds ratio of dying after FSI
implementation, 0.37; 95% CI, 0.22-0.62).15
These results also provide estimates of the likely rates of
postoperativemortality over time at different levels of frailty,
and these estimates have potential to inform the shared deci-
sionmakingbetween surgeons andpatients. For example, pa-
tientswithRAI scoresbetween26and30haveassociatedmor-
tality risks of 20.3%at 6months, increasing to 32.0%at 1 year.
The associated 30-day mortality of only 9.5% might be per-
ceived as a better than 90% chance of survival, and thus sur-
geons and patients alike might persevere with surgical treat-
ment. However, with these reliable estimates of longer-term
Table 4. MultivariableModels Testing the Association of FSI ImplementationWith Survival, Controlling for Age, Frailty, and PredictedMortalitya
Model
30-d Survival 180-d Survival 365-d Survival
OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value
Model 1
FSI implementation 4.86 (2.94-8.04) <.001 4.02 (2.93-5.53) <.001 4.11 (3.07-5.52) <.001
Age 0.94 (0.92-0.96) <.001 0.94 (0.93-0.95) <.001 0.95 (0.94-0.96) <.001
RAI score 0.89 (0.88-0.91) <.001 0.90 (0.89-0.92) <.001 0.90 (0.89-0.91) <.001
Model 2
FSI implementation 4.39 (2.53-8.54) <.001 3.11 (2.17-4.48) <.001 3.22 (2.31-4.48) <.001
Age 0.94 (0.92-0.96) <.001 0.94 (0.93-0.95) <.001 0.95 (0.94-0.96) <.001
RAI score 0.89 (0.87-0.91) <.001 0.90 (0.88-0.91) <.001 0.89 (0.88-0.90) <.001
FSI implementation × frailty 1.24 (0.48-3.23) .66 2.10 (1.12-3.92) .02 2.08 (1.16-3.73) .01
Model 3
FSI implementation 3.55 (1.80-7.02) <.001 2.87 (1.98-4.16) <.001 2.97 (2.11-4.19) <.001
Age 0.94 (0.92-0.96) <.001 0.95 (0.93-0.96) <.001 0.95 (0.94-0.96) <.001
RAI score 0.90 (0.88-0.93) <.001 0.90 (0.89-0.92) <.001 0.90 (0.89-0.92) <.001
FSI implementation × frailty 1.41 (0.49-4.08) .53 2.19 (1.11-4.32) .02 1.88 (1.00-3.55) .051
Predicted mortality 0.06 (0.01-0.33) .001 0.04 (0.01-0.13) <.001 0.03 (0.01-0.09) <.001
Abbreviations: FSI, Frailty Screening Initiative; OR, odds ratio; RAI, Risk Analysis
Index.
a For the interaction between FSI implementation and frailty, patients were
considered frail if they had RAI scores of 21 or higher. Sample sizes for models 1
and 2 were 9153, 8667, and 8056 for the 30-day, 180-day, and 365-day
survival groups, respectively. Because 418 patients were missing data on the
predictedmortality based on Veterans Affairs Surgical Quality Improvement
Program algorithms, the sample sizes for model 3 were 8735, 8249, and 7638
for the 30-day, 180-day, and 365-day survival groups, respectively.
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mortality, it is likely that somepatientswill consider the risks
too great and forgo surgery. Such longer-term mortality esti-
mates are critical for shared decision making when the time
to treatment equipoise26 for the proposed surgery ap-
proaches or exceeds the patient’s expected life span.
Fromasystemsperspective, frailty screeningwith theRAI
has many advantages. First, because the RAI is based on the
deficit accumulation frailtymodel, it is easier to operational-
ize than functional assessments, such as the Fried frailty
phenotype.27However, because it includes 10 elements of the
Canadian Study of Health and Aging Frailty Index and be-
cause a similarly abbreviated version of the Canadian Study
of Health and Aging Frailty Index had excellent predictive
ability and discrimination compared with the Fried frailty
phenotype,27 it is likely that the RAI will also perform on par
with functional assessments of frailty. Second, because the
RAI encompasses multiple domains of frailty (comorbidity,
functional status, nutrition, and cognition), it represents a
more comprehensive frailty assessment than the modified
Frailty Index, the other deficit accumulation model of
frailty validated in surgical populations that only includes
domains of comorbidity and functional status. Third, the
RAI is the only surgical frailty measure to look beyond 30
days, predicting longer-term outcomes to 1 year. Fourth, the
current study reveals the ability to screen entire populations
of surgical patients with a precision that makes it flexible for
clinical use.
Limitations
Our findings are limited in several ways. Most important, al-
though we were able to control for frailty, we were unable to
account for patients who screened as frail and did not un-
dergo surgery. This limitation may be a source of significant
selection bias, although it is clear that surgeons continued to
operate on frail patients. Further research using a random-
ized controlleddesignwill benecessary to establish the causal
connection between the FSI and mortality outcomes. In ad-
dition, our QI intervention did not adhere to a formal postop-
erative intervention or prehabilitation protocol, thus limiting
our ability to infer the causative factor behind improvement.
Further research is required to standardize the approach and
discern which parts of the intervention are essential and in-
fluential. The generalizability of our findings is limited to a
single Veterans Affairs medical center, although the charac-
teristics of the cohort appear comparable tootherVeteransAf-
fairs populations. Last, although survival improved,weknow
littleabout thequalityof thesurviving life.Futurestudiesmust
confirm this assumption by assessing patient-centered out-
comes, such as quality of life and the patient-centeredness of
decisions.
Conclusions
To our knowledge, this is one of the first studies to document
the feasibility of facility-wide screening of frailty and how
implementation of an FSI is associated with improved sur-
vival at 30, 180, and 365 days.We also found that theRAI pre-
dicts postoperativemortality,with an initial calibrationof the
RAI topredictmortalityamongelectivesurgicalpatientswithin
aVeteransAffairspopulation.Dependingonthe thresholdcho-
sen, the RAI identifies 5% to 20% of the population as poten-
tially frail, and although further research is needed, there are
several plausible interventions to improve outcomes among
the frail through prehabilitation,28,29 patient-centered deci-
sionmaking,15 and rescue therapy. This project is timely in the
changinghealth care environment,which incentivizes value-
based care deployed to enhance population health. Hospitals
and surgeons are looking for replicable models that can effi-
ciently use existing resources and improve the quality and
safetyofsurgery inarapidlyagingpopulation.Thisstudybuilds
a platform for further investigation into the causal connec-
tions and mechanisms behind improved survival after sys-
tematic frailty screening inpreoperativepopulations.The sus-
tainability of FSI in the long term and implementation in
different settingswilldependon integrationwithclinicalwork-
flow, use of electronic medical records, and standardization
of intervention for frail patients.
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Invited Commentary
A Call for Frailty Screening in the Preoperative Setting
AnneM. Suskind, MD, MS; Emily Finlayson, MD, MS
Frailty is associatedwithan increased riskofundesirablepost-
operativeoutcomesacrosssurgicalsubspecialties, includingcom-
plications, lengthofstay,discharge toaskilledorassisted-living
facility,1-3andmorbidity.4With
the rapidly increasing older
population, frailtyassessment
in the preoperative setting is
becoming an increasingly important, yet rarely performed,
screening tool that is recommendedbyboth theAmericanCol-
lege of Surgeons and the AmericanGeriatric Society.5
In this issue of JAMA Surgery,Hall et al6 share their expe-
rience with the implementation of the Frailty Screening Ini-
tiative at aVeteransAffairsmedical center. Theyused theRisk
Analysis Index,which isadeficit accumulationmodelof frailty,
to identify frail individuals to undergo further review before
their anticipated operation. Compared with a historical con-
trol of patients in the same medical center before implemen-
tation of the Frailty Screening Initiative, patients who under-
went frailty screeninghadadecrease inoverallmortality from
1.6% to 0.7%. However, this decrease was most pronounced
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